Insulin Pens Market Growth Surges with $6.73 Billion Target by 2031
The global Insulin Pens Market is poised for significant growth, with projections estimating its value at $6.73 billion by 2031, expanding at a compound annual growth rate (CAGR) of 6.7% during the forecast period. This growth is fueled by a combination of factors, including the increasing prevalence of diabetes worldwide, advancements in insulin pen technology, rising demand for self-administered drugs, and heightened awareness regarding diabetes management.